Literature DB >> 9854076

Detection of Pneumocystis carinii DNA in blood specimens from human immunodeficiency virus-infected patients by nested PCR.

M Rabodonirina1, L Cotte, A Boibieux, K Kaiser, M Mayencon, D Raffenot, C Trepo, D Peyramond, S Picot.   

Abstract

The detection of Pneumocystis carinii DNA in blood by PCR could be useful for studying the natural history of pneumocystosis and could also be a noninvasive diagnostic method. The results of previous studies are nevertheless conflicting. In our study, we compared three commercially available DNA extraction kits (GeneReleaser, QIAamp Tissue Kit, and ReadyAmp Genomic DNA Purification System) and proteinase K and proteinase K-phenol-chloroform treatments for the extraction of P. carinii DNA from dilutions of a P. carinii f. sp. hominis cyst suspension mixed with human whole blood. A rapid and simple nested PCR protocol which amplifies a portion of the mitochondrial large-subunit rRNA gene was applied to all the extraction products. The QIAmp Tissue Kit was the most effective kit for the isolation of amplification-ready P. carinii DNA and was used with nested PCR for the testing of whole-blood specimens from 35 immunocompetent control patients and 84 human immunodeficiency virus (HIV)-infected patients investigated for pulmonary disease and/or fever. In HIV-infected patients, P. carinii DNA was detected by nested PCR in blood samples from 3 of 14 patients with microscopically proven P. carinii pneumonia, 7 of 22 patients who were considered to be colonized with P. carinii, and 9 of 48 patients who were neither infected nor colonized with P. carinii. P. carinii DNA was not detected in blood specimens from the 35 immunocompetent patients. P. carinii DNA in blood might represent viable P. carinii organisms or DNA complexes released from pulmonary phagocytes. In conclusion, P. carinii DNA may be detected in whole blood from HIV-infected patients, but the nature and the meaning of the circulating form of P. carinii remain to be established.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9854076      PMCID: PMC84186     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Intravascular and pleural involvement by Pneumocystis carinii in a patient with the acquired immunodeficiency syndrome (AIDS)

Authors:  T S Dyner; W Lang; D F Busch; P R Gordon
Journal:  Ann Intern Med       Date:  1989-07-01       Impact factor: 25.391

2.  A clinical, histopathologic, and electron microscopic study of Pneumocystis carinii choroiditis.

Authors:  N A Rao; P L Zimmerman; D Boyer; J Biswas; D Causey; J Beniz; P W Nichols
Journal:  Am J Ophthalmol       Date:  1989-03-15       Impact factor: 5.258

3.  Digital necrosis and disseminated Pneumocystis carinii infection after aerosolized pentamidine prophylaxis.

Authors:  R T Davey; D Margolis; D Kleiner; L Deyton; W Travis
Journal:  Ann Intern Med       Date:  1989-10-15       Impact factor: 25.391

4.  Pneumocystis carinii pneumonia in three full-term siblings.

Authors:  G R Bazaz; O L Manfredi; R G Howard; A A Claps
Journal:  J Pediatr       Date:  1970-05       Impact factor: 4.406

5.  Amplification of mitochondrial ribosomal RNA sequences from Pneumocystis carinii DNA of rat and human origin.

Authors:  A E Wakefield; F J Pixley; S Banerji; K Sinclair; R F Miller; E R Moxon; J M Hopkin
Journal:  Mol Biochem Parasitol       Date:  1990-11       Impact factor: 1.759

6.  Improved diagnosis of Pneumocystis carinii infection by polymerase chain reaction on induced sputum and blood.

Authors:  G Y Lipschik; V J Gill; J D Lundgren; V A Andrawis; N A Nelson; J O Nielsen; F P Ognibene; J A Kovacs
Journal:  Lancet       Date:  1992-07-25       Impact factor: 79.321

7.  DNA amplification in experimental pneumocystosis: characterization of serum Pneumocystis carinii DNA and potential P. carinii carrier states.

Authors:  K Sepkowitz; N Schluger; T Godwin; D Armstrong; A Cerami; R Bucala
Journal:  J Infect Dis       Date:  1993-08       Impact factor: 5.226

8.  Detection of Pneumocystis carinii sequences by polymerase chain reaction: animal models and clinical application to noninvasive specimens.

Authors:  K Kitada; S Oka; S Kimura; K Shimada; T Serikawa; J Yamada; H Tsunoo; K Egawa; Y Nakamura
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

9.  Usefulness of PCR for detection of Pneumocystis carinii DNA.

Authors:  P Roux; I Lavrard; J L Poirot; C Chouaid; M Denis; J L Olivier; M Nigou; M Miltgen
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

10.  Application of DNA amplification to pneumocystosis: presence of serum Pneumocystis carinii DNA during human and experimentally induced Pneumocystis carinii pneumonia.

Authors:  N Schluger; T Godwin; K Sepkowitz; D Armstrong; E Bernard; M Rifkin; A Cerami; R Bucala
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  7 in total

1.  Comparison of various sample preparation methods for PCR diagnosis of visceral leishmaniasis using peripheral blood.

Authors:  L Lachaud; E Chabbert; P Dubessay; J Reynes; J Lamothe; P Bastien
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 2.  Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches.

Authors:  Marjorie Bateman; Rita Oladele; Jay K Kolls
Journal:  Med Mycol       Date:  2020-11-10       Impact factor: 4.076

3.  Accuracy of Pneumocystis jirovecii Plasma Cell-Free DNA PCR for Noninvasive Diagnosis of Pneumocystis Pneumonia.

Authors:  Angel Moreno; David Epstein; Indre Budvytiene; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2022-04-07       Impact factor: 11.677

4.  Simian immunodeficiency virus infection potently modulates chemokine networks and immune environments in hilar lymph nodes of cynomolgus macaques.

Authors:  Shulin Qin; Beth A F Junecko; Carissa M Lucero; Cynthia R Klamar; Anita M Trichel; Michael A Murphey-Corb; Patrick M Tarwater; Denise E Kirschner; Todd A Reinhart
Journal:  J Acquir Immune Defic Syndr       Date:  2013-08-01       Impact factor: 3.731

Review 5.  The unmasking of Pneumocystis jiroveci pneumonia during reversal of immunosuppression: case reports and literature review.

Authors:  Alan K L Wu; Vincent C C Cheng; Bone S F Tang; Ivan F N Hung; Rodney A Lee; David S Hui; Kwok Y Yuen
Journal:  BMC Infect Dis       Date:  2004-12-09       Impact factor: 3.090

6.  Pneumocystis pneumonia in children - the relevance of chemoprophylaxis in different groups of immunocompromised and immunocompetent paediatric patients.

Authors:  Olga Zajac-Spychała; Ewelina Gowin; Piotr Fichna; Jacek Wysocki; Marta Fichna; Arleta Kowala-Piaskowska; Iwona Mozer-Lisewska; Jerzy Nowak; Danuta Januszkiewicz-Lewandowska
Journal:  Cent Eur J Immunol       Date:  2015-04-22       Impact factor: 2.085

7.  Enzymatic treatment of specimens before DNA extraction directly influences molecular detection of infectious agents.

Authors:  Pablo Goldschmidt; Sandrine Degorge; Lilia Merabet; Christine Chaumeil
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.